Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637457, Singapore.
School of Materials Science and Engineering, Nanyang Technological University, Singapore 637335, Singapore.
Acta Biomater. 2018 Jul 1;74:1-16. doi: 10.1016/j.actbio.2018.04.034. Epub 2018 Apr 22.
UNLABELLED: Bioadhesives such as tissue adhesives, hemostatic agents, and tissue sealants have gained increasing popularity in different areas of clinical operations during the last three decades. Bioadhesives can be categorized into internal and external ones according to their application conditions. External bioadhesives are generally applied in topical medications such as wound closure and epidermal grafting. Internal bioadhesives are mainly used in intracorporal conditions with direct contact to internal environment including tissues, organs and body fluids, such as chronic organ leak repair and bleeding complication reduction. This review focuses on internal bioadhesives that, in contrast with external bioadhesives, emphasize much more on biocompatibility and adhesive ability to wet surfaces rather than on gluing time and intensity. The crosslinking mechanisms of present internal bioadhesives can be generally classified as follows: 1) chemical conjugation between reactive groups; 2) free radical polymerization by light or redox initiation; 3) biological or biochemical coupling with specificity; and 4) biomimetic adhesion inspired from natural phenomena. In this review, bioadhesive products of each class are summarized and discussed by comparing their designs, features, and applications as well as their prospects for future development. STATEMENT OF SIGNIFICANCE: Despite the emergence of numerous novel bioadhesive formulations in recent years, thus far, the classification of internal and external bioadhesives has not been well defined and universally acknowledged. Many of the formulations have been proposed for treatment of several diseases even though they are not applicable for such conditions. This is because of the lack of a systematic standard or evaluation protocol during the development of a new adhesive product. In this review, the definition of internal and external bioadhesives is given for the first time, and with a focus on internal bioadhesives, the criteria of an ideal internal bioadhesive are adequately discussed; this is followed by the review of recently developed internal bioadhesives based on different gluing mechanisms.
未加标签:在过去三十年中,生物黏合剂(如组织黏合剂、止血剂和组织密封剂)在不同的临床操作领域越来越受欢迎。根据其应用条件,生物黏合剂可分为内用型和外用型。外用生物黏合剂通常用于局部用药,如伤口闭合和表皮移植。内用型生物黏合剂主要用于与内部环境直接接触的体内情况,包括组织、器官和体液,如慢性器官漏修复和减少出血并发症。本综述重点介绍内用生物黏合剂,与外用生物黏合剂相比,它更强调生物相容性和对湿表面的黏附能力,而不是黏合时间和强度。目前内用生物黏合剂的交联机制一般可分为以下几类:1)反应基团之间的化学偶联;2)光或氧化还原引发的自由基聚合;3)特异性的生物或生化偶联;以及 4)受自然现象启发的仿生黏附。在本综述中,通过比较每种类型的生物黏合剂产品的设计、特点和应用以及它们未来发展的前景,对其进行了总结和讨论。
意义声明:尽管近年来出现了许多新型生物黏合剂配方,但迄今为止,内用型和外用型生物黏合剂的分类尚未得到很好的定义和普遍认可。许多配方已经被提出用于治疗多种疾病,尽管它们不适用于这些疾病。这是因为在新黏合剂产品的开发过程中缺乏系统的标准或评估方案。在本综述中,首次对内用型和外用型生物黏合剂进行了定义,并重点介绍了内用型生物黏合剂,充分讨论了理想的内用型生物黏合剂的标准;随后根据不同的黏合机制对最近开发的内用型生物黏合剂进行了综述。
Acta Biomater. 2018-4-22
Macromol Biosci. 2022-2
Adv Mater. 2023-12
Adv Healthc Mater. 2019-4-3
Macromol Biosci. 2012-12-6
Acta Biomater. 2022-9-15
Int J Biol Macromol. 2024-1
Front Bioeng Biotechnol. 2021-9-3
Acta Biomater. 2018-3-17
Int J Pharm X. 2025-7-15
Fundam Res. 2024-2-29
Materials (Basel). 2025-1-15
Annu Conf Expo (Am Soc Eng Educ). 2023-6-25
Bioengineering (Basel). 2024-10-12
Smart Med. 2023-10-7
Signal Transduct Target Ther. 2024-7-1
Kardiochir Torakochirurgia Pol. 2024-3
Mater Today Bio. 2024-2-10